What's in Università degli Studi di Ferrara's pipeline?

Università degli Studi di Ferrara has 7 drugs in our index: 6 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Università degli Studi di Ferrara's portfolio?

Top competitors by shared drug class: Beijing Tiantan Hospital, Centocor, Inc., General Hospital of Shenyang Military Region, Ivan Sofian Wibowo, Ministry of Science and Technology of the People´s Republic of China.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/universit-degli-studi-di-ferrara.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Università degli Studi di Ferrara — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Università degli Studi di Ferrara pipeline: 6 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

6 marketed 0 filed 0 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
bolus+infusion	bolus+infusion	marketed
Mepolizumab 100 MG	Mepolizumab 100 MG	marketed
Blood component A	Blood component A	marketed
Blood component B	Blood component B	marketed
Bronchodilator Agents	Bronchodilator Agents	marketed	Bronchodilator		Respiratory
abciximab bolus only regimen	abciximab bolus only regimen	marketed	Glycoprotein IIb/IIIa inhibitor	Glycoprotein IIb/IIIa integrin receptor	Cardiovascular

Therapeutic area mix

Cardiovascular · 1
Respiratory · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Beijing Tiantan Hospital · 1 shared drug class
Centocor, Inc. · 1 shared drug class
General Hospital of Shenyang Military Region · 1 shared drug class
Ivan Sofian Wibowo · 1 shared drug class
Ministry of Science and Technology of the People´s Republic of China · 1 shared drug class
Organon and Co · 1 shared drug class
Ottawa Heart Institute Research Corporation · 1 shared drug class
University of Leipzig · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Università degli Studi di Ferrara:

Cite this brief

Drug Landscape (2026). Università degli Studi di Ferrara — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universit-degli-studi-di-ferrara. Accessed 2026-05-17.